BRPI0608042A2 - composições compreendendo actinidia e métodos para o uso desta - Google Patents

composições compreendendo actinidia e métodos para o uso desta

Info

Publication number
BRPI0608042A2
BRPI0608042A2 BRPI0608042-1A BRPI0608042A BRPI0608042A2 BR PI0608042 A2 BRPI0608042 A2 BR PI0608042A2 BR PI0608042 A BRPI0608042 A BR PI0608042A BR PI0608042 A2 BRPI0608042 A2 BR PI0608042A2
Authority
BR
Brazil
Prior art keywords
fruit
kiwi
preparation
mammal
actinidia
Prior art date
Application number
BRPI0608042-1A
Other languages
English (en)
Inventor
Julianne Lindemann
George E Stagnitti
Robert H Driver
Mark A Braman
Nacy E Fogg-Johnson
Sunyoung Kim
Mirim Jin
Hyung-Jin Jung
Sung-Seup Shin
Jin-Hwan Oh
Hwa-Jun Lee
Hyang Jeon
Eun-Jin Park
Bongcheol Kim
Original Assignee
Pangenomics Co Ltd
Efficas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pangenomics Co Ltd, Efficas Inc filed Critical Pangenomics Co Ltd
Publication of BRPI0608042A2 publication Critical patent/BRPI0608042A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

COMPOSIçõES COMPREENDENDO ACTINIDIA E MéTODOS PARA O USO DESTA. Onde uma configuração da presente invenção refere-se a um método para regular uma resposta imune em um mamífero; o método inclui administrar um preparo de kiwi resistente ao mamífero em uma quantia suficiente para regular uma resposta imune no mamífero, onde o preparo de kiwi resistente é selecionado a partir de: fruta fresca, fruta amassada, fruta fervida, fruta cozida, fruta espremida, fruta condensada, fruta seca e um concentrado de suco de kiwi resistente. Nesta configuração, o preparo de kiwi resistente não foi extraído; em um aspecto da configuração acima, o preparo e kiwi resistente é produzido por um método que inclui uma etapa de secagem da fruta.
BRPI0608042-1A 2005-02-25 2006-02-24 composições compreendendo actinidia e métodos para o uso desta BRPI0608042A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65683805P 2005-02-25 2005-02-25
US65683905P 2005-02-25 2005-02-25
PCT/US2006/006437 WO2006093793A2 (en) 2005-02-25 2006-02-24 Compositions comprising actinidia and methods of use thereof

Publications (1)

Publication Number Publication Date
BRPI0608042A2 true BRPI0608042A2 (pt) 2009-11-03

Family

ID=36941647

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0608042-1A BRPI0608042A2 (pt) 2005-02-25 2006-02-24 composições compreendendo actinidia e métodos para o uso desta

Country Status (8)

Country Link
EP (1) EP1858535A4 (pt)
JP (1) JP2008531584A (pt)
AU (1) AU2006218875B2 (pt)
BR (1) BRPI0608042A2 (pt)
MX (1) MX2007010408A (pt)
RU (1) RU2423139C2 (pt)
TW (1) TWI385007B (pt)
WO (1) WO2006093793A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080175888A1 (en) * 2005-02-25 2008-07-24 Julie Lindemann Combination Therapy Comprising Actinidia and Steroids and Uses Thereof
DE102006055210A1 (de) * 2006-11-21 2008-05-29 Ionescu, John G., Dr. Diätisches Lebensmittel mit erhöhter freie Radikale bindender Wirkung
KR101141182B1 (ko) 2009-05-12 2012-05-02 재단법인 제주테크노파크 항염증성 조성물
TWI583312B (zh) 2009-08-12 2017-05-21 梅拉洛伊卡公司 用於治療疼痛與發炎的膳食補充品及方法
JP4750202B2 (ja) * 2009-10-16 2011-08-17 株式会社 藍匠 サルナシを用いた健康補助食品の製造方法
BR112012016054A2 (pt) * 2009-12-29 2015-09-01 Nestec Sa Composições nutricionais compreendendo flocos de fruta incluindo ácido docosa-hexaenoico
JP5688233B2 (ja) * 2010-04-23 2015-03-25 ポーラ化成工業株式会社 Ｔａｒｃ産生抑制剤
JP6179840B2 (ja) * 2011-11-30 2017-08-16 国立大学法人 岡山大学 サルナシ由来の高極性有機溶媒抽出物とその利用
JP6242669B2 (ja) * 2013-11-27 2017-12-06 日本メナード化粧品株式会社 サルナシ抽出物を含有するヒアルロン酸生成促進剤
CN105410588B (zh) * 2015-11-06 2018-05-08 四川兴食尚科技有限公司 一种猕猴桃泡腾片及其制备工艺
AU2019272800A1 (en) * 2018-05-22 2020-12-03 N.V. Nutricia Biomarkers for improving nutrion for infants at risk

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242814A (en) * 1989-10-10 1993-09-07 Eli Lilly And Company Polyether antibiotic
CA2246162C (en) * 1996-01-23 2000-04-04 Icn Pharmaceuticals, Inc. Modulation of th1/th2 cytokine expression by ribavirin.rtm. and ribavirin.rtm. analogs in activated t-lymphocytes
US6046185A (en) * 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
DE19758090B4 (de) * 1997-12-18 2008-10-16 Maria Endres Zusammensetzung und deren Verwendung in Kosmetik und Medizin
JP2002302458A (ja) * 2000-12-26 2002-10-18 Takeda Chem Ind Ltd 併用薬
WO2002079372A1 (en) * 2001-03-29 2002-10-10 Council Of Scientific And Industrial Research Process for the preparation of herbal wines from himalayan berriers
US6811796B2 (en) * 2002-04-22 2004-11-02 Matsuura Yakugyo Co., Ltd. Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof
WO2003103415A1 (en) * 2002-06-07 2003-12-18 Ann De Wees Allen Novel sweetener compositions and methods of use
KR100615389B1 (ko) * 2002-08-23 2006-08-25 (주)헬릭서 다래 추출물을 함유하는 알러지성 질환 및 비알러지성염증 질환의 예방 및 개선용 건강 기능 식품

Also Published As

Publication number Publication date
EP1858535A4 (en) 2012-05-02
JP2008531584A (ja) 2008-08-14
AU2006218875B2 (en) 2012-08-09
WO2006093793A3 (en) 2006-12-07
EP1858535A2 (en) 2007-11-28
RU2007135365A (ru) 2009-03-27
TWI385007B (zh) 2013-02-11
WO2006093793A2 (en) 2006-09-08
AU2006218875A1 (en) 2006-09-08
RU2423139C2 (ru) 2011-07-10
TW200716226A (en) 2007-05-01
WO2006093793A8 (en) 2008-03-27
MX2007010408A (es) 2008-03-25

Similar Documents

Publication Publication Date Title
Ghasemzadeh et al. Optimization of reflux conditions for total flavonoid and total phenolic extraction and enhanced antioxidant capacity in pandan (Pandanus amaryllifolius Roxb.) using response surface methodology
BRPI0608042A2 (pt) composições compreendendo actinidia e métodos para o uso desta
BR112012017683A2 (pt) Emulsões nutritivas compreendendo hmb de calcio e proteina soluvel
MX385771B (es) Composiciones de flavonoide y métodos de uso.
BR112014014686A2 (pt) composição flavorizante umami a partir de processamento vegetal
EA201200242A1 (ru) Сублимационно высушенные аэрированные фруктовые или овощные композиции и способ их приготовления
EA201001044A1 (ru) Умами-активная фракция и способ её приготовления
CY1124010T1 (el) Μια φαρμακευτικη συνθεση για την παρεμποδιση της διατροφικης παχυσαρκιας
DK1737300T3 (da) Tilföring af et additiv til et produkt, som er egnet som menneskelig föde
BR112012011604A2 (pt) intensificadores de flavour natural e método de produção dos mesmos
MY190273A (en) Dietary supplements and compositions for enhancing physical performance and energy levels
Zhou et al. A modified and improved assay based on microbial test system (MTS) to evaluate antioxidant activity
DK1855551T3 (da) Fremgangsmåde til fremstilling af pölseprodukter
Valerga et al. Antioxidant activity of yerba mate extracts: Interactions between the individual polyphenols
MX381955B (es) Metodo para almacenar sustancias en solidos organicos.
BR112021023971A2 (pt) Proteína de legumes coatomizada com sabor e aroma reduzidos
RU2018110600A (ru) Экстракты стевии
AR105515A1 (es) Concentrado salado que comprende sal inorgánica, grasa y goma gellan
MX391376B (es) Composiciones de la membrana de la cáscara del huevo para usarse en el tratamiento de la cadena ligera kappa del factor nuclear de las células b activadas (nf-kb) en un organismo hospedero.
ATE504216T1 (de) Getränk enthaltend funktionelle zutaten zur verhinderung von durch oxidationsmittel hervorgerufenen degenerativen phänomenen
Mondaca‐Navarro et al. Obtaining glycoconjugates of marine origin via Maillard reaction and their cytotoxic effect: an alternative for the use of animal byproducts
UA112072C2 (uk) Спосіб одержання стабільної харчової емульсії масло-у-воді, що не містить харчових добавок
TR200700172A2 (tr) Gıda ürünü.
BRPI0514875A (pt) auxiliar de arte culinária estável em prateleira e um processo para sua preparação
EP1449440A3 (fr) Procédé de conservation de végétaux, et en particulier de fruits

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.